NCT06286046View on ClinicalTrials.gov

A Study of Mitapivat in Participants With Sickle Cell Disease and Nephropathy

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 31, 2026

Primary Completion Date

May 31, 2027

Study Completion Date

December 31, 2028

Conditions
Sickle Cell DiseaseNephropathy
Interventions
DRUG

Mitapivat

Tablets

Sponsors
All Listed Sponsors
lead

Agios Pharmaceuticals, Inc.

INDUSTRY